{"lastClose": 5.889999866485596, "len": 683, "date": "2023-04-11", "alpha_1": -0.5320109727278064, "beta_1": 0.6166279091054208, "drawup_1": 4.609523937112896, "natr_1": 8.179315311730567, "sup_1": -0.12925860185782997, "res_1": 0.052292056694239294, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 71.32049598413883, "adx_1": 48.90261332521611, "drawdown_1": -0.8073394515480059, "stratHoldSharpe_1": 0.5732309018690983, "stratHoldAlpha_1": 251.5109612992614, "stratHoldDrawdown_1": -0.7304925304921144, "alpha_3mo": 65.56873046114339, "beta_3mo": 0.8427340649359694, "drawup_3mo": 2.4444442895265928, "sharpe_3mo": 4.500516159131285, "natr_3mo": 8.179315311730567, "sup_3mo": -0.027164660617823914, "res_3mo": 0.18845503542883973, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 78.16205736596635, "adx_3mo": 74.28281219257663, "drawdown_3mo": -0.23076918588138473, "stratHoldSharpe_3mo": 4.895010275008276, "stratHoldAlpha_3mo": 256.5346493983471, "stratHoldDrawdown_3mo": -0.21615716261752727, "Industry": "Biotechnology: Pharmaceutical Preparations", "Name": "Inozyme Pharma Inc.", "Sector": "Health Care", "Market Cap": 257510841, "IPO Year": 2020.0, "Country": "United States", "alpha%_1": 0.05082517134150659, "beta%_1": 0.2250405250836358, "drawup%_1": 1.0, "natr%_1": 0.9528689022514013, "drawdown%_1": 0.01069739418641325, "stratHoldSharpe%_1": 0.7681649747935382, "stratHoldAlpha%_1": 0.9681531454877883, "stratHoldDrawdown%_1": 0.011207738711094904, "alpha%_3mo": 1.0, "beta%_3mo": 0.3708817758896118, "drawup%_3mo": 1.0, "sharpe%_3mo": 0.9925873735846104, "natr%_3mo": 0.9493052035402318, "drawdown%_3mo": 0.4018235502051513, "stratHoldSharpe%_3mo": 0.9979121106845793, "stratHoldAlpha%_3mo": 1.0, "stratHoldDrawdown%_3mo": 0.3789792690396483}